Innere Medizin up2date, Table of Contents Diabetologie und Stoffwechsel 2014; 2(03): 179-191DOI: 10.1055/s-0034-1387248 Herz, Kreislauf und Gefäße © Georg Thieme Verlag KG Stuttgart · New YorkDiagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK) Authors Holger Lawall Claas Luedemann Recommend Article Abstract Buy Article(opens in new window) All articles of this category(opens in new window) See also:Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK)Diabetologie und Stoffwechsel 2011; 6(06): 71-82DOI: 10.1055/s-0031-1283836 Full Text References Literatur 1 Lawall H, Diehm C, Pittrow D. Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin Hrsg. Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK). VASA 2009; 38 (Suppl. 75) 1-72 2 Criqui MH, Fronek A, Barrett-Connor E et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-515 3 Diehm C, Schuster A, Allenberg H et al. High prevalence of peripheral arterial disease and comorbidity in 6,880 primary care patients: cross sectional study. Atherosclerosis 2004; 172: 95-105 4 Kröger K, Stang A, Kondratieva J et al. Prevalence of peripheral arterial disease-results of the Heinz Nixdorf recall study. Eur J Epidemiol 2006; 21: 279-285 5 Sigvant B, Wiberg-Hedmann K, Bergquist D et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007; 45: 1185-1191 6 Malyar N et al. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. Eur Heart J 2013; 34: 2706-2714 7 Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994; 1: 333-339 8 Steg PG, Bhatt DL, Wilson PW et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197-1206 9 Diehm C, Allenberg J-R, Haberl R et al. High all-cause mortality in patients with peripheral arterial disease in primary care: Five-year results of the getABI study [abstract 3701]. Circulation 2007; 116: II_841-b 10 Adam DJ, Beard JD, Cleveland T et al. Bypass versus angioplasty in severe ischaemia oft the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934 11 Diehm C, Darius H, Burghaus I et al. Ankle brachial index vs metabolic syndrome for risk prediction. Lancet 2008; 372: 1221 12 Ridker PM, Stampfer MJ, Rifal N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a) and cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285: 2481-2485 13 Schröder F, Diehm N, Kareem S et al. A modified calculation of ankle-brachial pressure index is far more sensitive in the detection of periphereal arterial disease. J Vasc Surg 2006; 44: 531-536 14 Andersen CA. Noninvasive assessment of lower extremity hemodynamics in individuals with diabetes mellitus. J Vasc Surg 2010; 52: 76S-80S 15 Schaper NC, Andros G, Apelquist J et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2012; 28: 218-224 16 Collins R, Burch J, Cranny G et al. Duplexsonography, magnetic resonance angiography and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systemic review. BMJ 2007; 334: 1257 17 Spronk S et al. Intermittent claudication: Clinical effectiveness of endovascular revascularisation versus supervised hospital-based exercise Training- randomised clinical trial. Radiology 2009; 250: 586-595 18 Cochrane Data Base: Clinical evidence in claudication intermittens. Cochrane Library 2007; (01) CD 003748 19 Murphy TP, Cutlip DE, Regensteiner JG et al. Supervised exercise vs primary stenting for claudication due to aortoiliac peripheral arterial disease: 6 months outcomes from the CLEVER Study. Circulation 2012; 125: 130-139 20 Tendera M, Aboyans V, Bartelink ML et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J 2011; 21 Lawall H, Diehm C. Update Angiologie. Med Klin 2008; 103: 195-209 22 Norgren L, Hiatt W, Dormandy J et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl. 01) S1-S75 23 Morbach S, Müller E, Reike H et al. Diabetisches Fuß-Syndrom. Praxisleitlinie DDG. Diabetologie 2013; 8: 180-188 24 Faglia E, Dalla Paola L, Clerici G et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 2005; 29: 620-627 25 Albers M, Battistella VM, Romiti M et al. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 2003; 37: 1263-1269 26 Albers M, Romiti M, Brochado-Neto FC et al. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg 2006; 43: 498-503 27 Kudo T, Chandra FA, Kwun WH et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg 2006; 44: 304-313 28 Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-1888 29 Werth S, Halbritter K, Mahlmann A et al. Katheterinterventionelle Therapie bei peripherer arterieller Verschlusskrankheit und diabetischer Angiopathie. DMW 2011; 136: 1994-1997 30 Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998; 338: 1105-1111 31 Vandvik PO, Lincoff AM, Gore JM et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic therapy and prevention of thrombosis. Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th Edition). Chest 2012; 141 (Suppl. 02) S 637-668 32 Tepe G, Bnatleon R, Brechtel K et al. Management of peripheral arterial interventions with mono or dual antiplatelet therapy-the MIRROR study: a randomised and double-blinded clinical trial. Eur J Radiology 2012; 22: 1998-2006